S114: PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATED RESULTS FROM A PHASE II STUDY

Bibliographic Details
Main Authors: N. Short, H. Kantarjian, M. Konopleva, N. Jain, F. Ravandi, X. Huang, W. Macaron, W. Wierda, G. Borthakur, T. Kadia, K. Sasaki, G. Issa, G. Montalban-Bravo, Y. Alvarado, G. Garcia-Manero, C. Dinardo, J. Thankachan, R. Delumpa, E. Mayor, W. Deen, A. Milton, J. Rivera, L. Waller, C. Loiselle, R. Garris, E. Jabbour
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000843352.55138.40
_version_ 1797281731952246784
author N. Short
H. Kantarjian
M. Konopleva
N. Jain
F. Ravandi
X. Huang
W. Macaron
W. Wierda
G. Borthakur
T. Kadia
K. Sasaki
G. Issa
G. Montalban-Bravo
Y. Alvarado
G. Garcia-Manero
C. Dinardo
J. Thankachan
R. Delumpa
E. Mayor
W. Deen
A. Milton
J. Rivera
L. Waller
C. Loiselle
R. Garris
E. Jabbour
author_facet N. Short
H. Kantarjian
M. Konopleva
N. Jain
F. Ravandi
X. Huang
W. Macaron
W. Wierda
G. Borthakur
T. Kadia
K. Sasaki
G. Issa
G. Montalban-Bravo
Y. Alvarado
G. Garcia-Manero
C. Dinardo
J. Thankachan
R. Delumpa
E. Mayor
W. Deen
A. Milton
J. Rivera
L. Waller
C. Loiselle
R. Garris
E. Jabbour
author_sort N. Short
collection DOAJ
first_indexed 2024-03-07T17:01:41Z
format Article
id doaj.art-2317444c8bc146f699cb708ace9ddc46
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T17:01:41Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-2317444c8bc146f699cb708ace9ddc462024-03-03T03:19:23ZengWileyHemaSphere2572-92412022-06-016151610.1097/01.HS9.0000843352.55138.40202206003-00015S114: PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATED RESULTS FROM A PHASE II STUDYN. Short0H. Kantarjian1M. Konopleva2N. Jain3F. Ravandi4X. Huang5W. Macaron6W. Wierda7G. Borthakur8T. Kadia9K. Sasaki10G. Issa11G. Montalban-Bravo12Y. Alvarado13G. Garcia-Manero14C. Dinardo15J. Thankachan16R. Delumpa17E. Mayor18W. Deen19A. Milton20J. Rivera21L. Waller22C. Loiselle23R. Garris24E. Jabbour251 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia2 Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, United States of America1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemia1 Department of Leukemiahttp://journals.lww.com/10.1097/01.HS9.0000843352.55138.40
spellingShingle N. Short
H. Kantarjian
M. Konopleva
N. Jain
F. Ravandi
X. Huang
W. Macaron
W. Wierda
G. Borthakur
T. Kadia
K. Sasaki
G. Issa
G. Montalban-Bravo
Y. Alvarado
G. Garcia-Manero
C. Dinardo
J. Thankachan
R. Delumpa
E. Mayor
W. Deen
A. Milton
J. Rivera
L. Waller
C. Loiselle
R. Garris
E. Jabbour
S114: PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATED RESULTS FROM A PHASE II STUDY
HemaSphere
title S114: PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATED RESULTS FROM A PHASE II STUDY
title_full S114: PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATED RESULTS FROM A PHASE II STUDY
title_fullStr S114: PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATED RESULTS FROM A PHASE II STUDY
title_full_unstemmed S114: PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATED RESULTS FROM A PHASE II STUDY
title_short S114: PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATED RESULTS FROM A PHASE II STUDY
title_sort s114 ponatinib and blinatumomab for patients with philadelphia chromosome positive acute lymphoblastic leukemia updated results from a phase ii study
url http://journals.lww.com/10.1097/01.HS9.0000843352.55138.40
work_keys_str_mv AT nshort s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT hkantarjian s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT mkonopleva s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT njain s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT fravandi s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT xhuang s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT wmacaron s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT wwierda s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT gborthakur s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT tkadia s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT ksasaki s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT gissa s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT gmontalbanbravo s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT yalvarado s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT ggarciamanero s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT cdinardo s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT jthankachan s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT rdelumpa s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT emayor s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT wdeen s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT amilton s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT jrivera s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT lwaller s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT cloiselle s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT rgarris s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy
AT ejabbour s114ponatinibandblinatumomabforpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiaupdatedresultsfromaphaseiistudy